Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology.
about
Neurodegeneration with brain iron accumulation: update on pathogenic mechanismsMagnesium inhibits spontaneous and iron-induced aggregation of alpha-synucleinInhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compoundsMultiple system atrophy: cellular and molecular pathology.Secondary structure and dynamics of micelle bound beta- and gamma-synucleinThe Synaptic Function of α-SynucleinRole of α- and β-Synucleins in the Axonal Pathology of Parkinson's Disease and Related SynucleinopathiesClinical and genetic delineation of neurodegeneration with brain iron accumulationNeurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the geneGamma-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein.A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brainNeurodegeneration with brain iron accumulation: an overview.Neurodegeneration with brain iron accumulation.Iron metabolism in Parkinsonian syndromes.Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration.Curcumin inhibits aggregation of alpha-synuclein.Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.Selective pattern of motor system damage in gamma-synuclein transgenic mice mirrors the respective pathology in amyotrophic lateral sclerosis.Iron and Parkinson's disease.Tau-predominant-associated pathology in a sporadic late-onset Hallervorden-Spatz syndrome.Genetics of parkinsonism.Cell-specific post-transcriptional regulation of γ-synuclein gene by micro-RNAs.Gamma-synuclein pathology in amyotrophic lateral sclerosisNovel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegenerationIron in neurodegenerative disorders.Neuropathology in succinic semialdehyde dehydrogenase deficiency.The muscle protein dysferlin accumulates in the Alzheimer brain.E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairmentDiagnostic considerations in juvenile parkinsonism.Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse modelNeuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies.Possible alterations in β-Synuclein, the non-amyloidogenic homologue of α-Synuclein, during progression of sporadic α-synucleinopathiesDisrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutationsDiversity of mitochondrial pathology in a mouse model of axonal degeneration in synucleinopathies.Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations.The importance of hemosiderin deposition in the infant brain: an autopsy study.Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease.Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases.Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patients.Novel antibodies to phosphorylated α-synuclein serine 129 and NFL serine 473 demonstrate the close molecular homology of these epitopes
P2860
Q21129274-93076EA0-125D-4E7E-AD22-FE9EA15CF66DQ24292317-27C5D3C0-EBE6-46E7-9A01-292DC7F8B77CQ24298231-D774869B-748C-4884-8AA4-466E381E1C46Q24535446-4FDE843B-A214-401D-B6C9-37A65498F2D8Q24647859-8951DA80-9364-4F26-9A67-13F17FE4E850Q27694711-050B0734-B483-43A6-9B57-44CF90DF3CC0Q28083418-E03245B8-A17D-4676-9A28-BC22D0180DC5Q28315639-211B9B2D-6636-4428-9066-4607C9AA7EB9Q28587583-10EB3247-2040-4C1F-8C7F-C5FFB4EF81EAQ30487162-5131CC11-9B42-49A8-867C-C28B73F6673DQ30498862-B936F31E-02DF-4E91-B0DC-A2979EB16886Q30888676-49F3891C-7837-48BD-B874-1798A7278E8AQ31029813-BBF97D87-7340-4FE5-878B-165AE01DAD9DQ33248678-A0ABA1C0-4E53-4631-85AD-563CF338A3D0Q33253340-92FB697F-9514-4ED9-A2B2-4F01D58E177FQ33314363-BE5520EC-D0F2-4085-8C5A-571D81AD9FDEQ33470625-56E3A9AD-E785-48E1-A51B-1D83FB9B14C3Q34323256-371DC60D-D945-404F-8205-0437D2B3F357Q34529356-BB393B61-C402-42D1-9858-48B5BC791CC9Q34560295-FAB19644-EA2B-4837-9433-E25E8A9782E0Q34811944-F0B00D44-EE7E-4B02-8A7D-2B57F73CAA8CQ34989307-C3575967-3012-401D-A3CE-CC73F41CE14DQ34994452-E58B70D2-27A0-493A-A4A7-DEA9BE31E6D5Q35018106-32D2B59A-66CD-4771-B41B-06CA6748801DQ35112542-553E81C7-C818-42D2-8E73-A715168AD661Q35162321-D3538A4F-9975-4C80-A934-F5E6E24CDBFDQ35230012-1D419452-5745-4F37-B33B-63B5C78F2FC0Q35266392-C1B903BA-9EF9-4CEF-9E49-8063F195445DQ35673290-B1AA0116-EE78-4C10-836B-A01C2A43D2E1Q35747138-56402227-C204-4FA2-B896-D3E6E1C6CA1DQ35884977-F88673B8-BA2D-4EEA-AAFD-B0A91C604C13Q36321837-C71B6985-F2A8-4B4E-ABEC-CAFDB96C07E1Q36559669-01058848-532A-4C29-AD13-47EAB36B36CFQ36729178-C3306E0C-693C-47E9-9B27-0DB79CC57F50Q36854793-3F72DB74-5FA7-4441-BEDA-5E9F86BBDDE8Q37078469-EE75B59B-4668-4920-A125-1220D5971BE4Q37105393-C782C3EE-98E8-42AA-8681-2303119D72B5Q37119983-37AE8EDD-CD6B-49D1-BF09-51F7C8BD0A2BQ37132181-239C8F0A-C713-45E0-A126-D741053AC416Q37160673-E277D708-A24D-42EB-A885-AE2CC41C9E40
P2860
Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Neurodegeneration with brain i ...... amma-synuclein neuropathology.
@ast
Neurodegeneration with brain i ...... amma-synuclein neuropathology.
@en
type
label
Neurodegeneration with brain i ...... amma-synuclein neuropathology.
@ast
Neurodegeneration with brain i ...... amma-synuclein neuropathology.
@en
prefLabel
Neurodegeneration with brain i ...... amma-synuclein neuropathology.
@ast
Neurodegeneration with brain i ...... amma-synuclein neuropathology.
@en
P2093
P2860
P1476
Neurodegeneration with brain i ...... amma-synuclein neuropathology.
@en
P2093
H I Hurtig
J E Galvin
J Q Trojanowski
P2860
P304
P356
10.1016/S0002-9440(10)64548-8
P407
P577
2000-08-01T00:00:00Z